Overview
Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system. In the WikiBiome context, GABA is notable because gut bacteria produce it — certain Lactobacillus and Bifidobacterium species possess glutamate decarboxylase (GAD) enzymes that convert dietary glutamate to GABA. This microbial GABA production links the gut brain axis to anxiety, depression, PMDD, and schizophrenia.
Microbial GABA Production
- lactobacillus reuteri, L. brevis, and bifidobacterium species are the primary GABA-producing gut bacteria.
- Microbial GABA acts locally on enteric neurons (vagal afferents) and may contribute to circulating GABA levels.
- Dysbiosis-driven loss of GABA-producing commensals is associated with anxiety and depressive phenotypes eskandar 2025 gut brain axis depression anxiety schizophrenia scoping review.
Disease Associations
- PMDD/PMS: GABAergic deficiency implicated in premenstrual mood dysregulation; allopregnanolone (a GABA-A receptor modulator) is central to PMDD pathophysiology itriyeva 2022 pms pmdd adolescents review cheng 2025 neuroinflammation pms pmdd review nexha 2024 biological rhythms pmdd systematic review.
- Schizophrenia: Altered GABA levels and GABAergic signaling in schizophrenia gut-brain axis ghorbani 2024 gut microbiome dopamine serotonin bdnf schizophrenia li 2021 gut microbiome brain structure function schizophrenia.
- MS: Dietary interventions targeting GABA pathways in multiple sclerosis atabilen 2022 dietary interventions ms systematic review.
Cross-References
- gut brain axis — GABA as microbial-derived neuroactive metabolite
- serotonin — complementary neurotransmitter in gut-brain signaling
- allopregnanolone — GABA-A modulator central to PMDD
- lactobacillus reuteri — GABA-producing commensal
- bifidobacterium — GABA-producing commensal
- neuroinflammation — GABAergic loss compounds neuroinflammatory damage